You have 6 free searches left this month | for more free features.

OPT-821

Showing 26 - 50 of 246

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Various: Health Insurance Members That Could Benefit From Being Connected to a Specialist, e.g., Orthopedic Doctor to Treat Back

Not yet recruiting
  • Various: Health Insurance Members That Could Benefit From Being Connected to a Specialist, e.g., Orthopedic Doctor to Treat Back Pain
  • Message variation 1
  • Message variation 2
  • (no location specified)
Apr 20, 2023

Palliative Care Trial (Generalist + Specialist palliative care, Active control alert)

Not yet recruiting
  • Palliative Care
  • Generalist + Specialist palliative care
  • Active control alert
  • (no location specified)
Aug 12, 2022

Hepatocellular Carcinoma, Cirrhosis Trial in Philadelphia (Usual care, Opt-out, Opt-out + Incentive)

Completed
  • Hepatocellular Carcinoma
  • Cirrhosis
  • Usual care
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Health System
Jul 28, 2022

Type 1 Diabetes Trial in Chicago (Sleep-Opt, Healthy Living)

Recruiting
  • Type 1 Diabetes
  • Sleep-Opt
  • Healthy Living
  • Chicago, Illinois
    University of Illinois Chicago
Mar 13, 2022

Port-Wine Stain, Rosacea, Telangiectasia Trial in Irvine (Optical Coherence Tomography)

Terminated
  • Port-Wine Stain
  • +3 more
  • Optical Coherence Tomography
  • Irvine, California
    University of California, Irvine
Jul 20, 2022

Tobacco Use, Tobacco Smoking, Tobacco Use Cessation Trial in Brooklyn (opt out enrollment, tailored counseling, varenicline

Not yet recruiting
  • Tobacco Use
  • +2 more
  • opt out enrollment, tailored counseling, varenicline started prior to target quit date
  • opt in enrollment, non-tailored counseling, varenicline started prior to target quit date
  • Brooklyn, New York
    FDNY World Trade Center Health Program
Aug 17, 2023

Verruca Vulgaris, Molluscum Contagiosum Trial (Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma

Not yet recruiting
  • Verruca Vulgaris
  • Molluscum Contagiosum
  • Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
  • (no location specified)
Jun 30, 2023

Smoking Cessation Trial in United States (Enhanced Care, Basic Care)

Active, not recruiting
  • Smoking Cessation
  • Enhanced Care
  • Basic Care
  • Charleston, South Carolina
  • +5 more
Jan 4, 2023

Virtual Reality, Colonoscopy Trial in Copenhagen (VR)

Not yet recruiting
  • Virtual Reality
  • Colonoscopy
  • VR
  • Copenhagen, Denmark
    Department of Gastroenterology, Herlev and Gentofte Hospital
Feb 1, 2023

Smoking Cessation Trial in New York (Opt-Out Reminder, Opt-In Reminder)

Completed
  • Smoking Cessation
  • Opt-Out Reminder
  • Opt-In Reminder
  • New York, New York
    NYU Langone Health
May 9, 2022

Haemoglobin Barts Hydrops Trial in Sha Tin (in-utero HSCT)

Recruiting
  • Haemoglobin Barts Hydrops
  • in-utero HSCT
  • Sha Tin, Hong Kong
    The Chinese University of Hong Kong
Mar 21, 2023

Autism Spectrum Disorder Trial (OPT-IN, Psychoeducational control)

Not yet recruiting
  • Autism Spectrum Disorder
  • OPT-IN
  • Psychoeducational control
  • (no location specified)
Aug 23, 2023

Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

Not yet recruiting
  • Inherited Bone Marrow Failure Syndrome
  • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 20, 2023

Mixed Dyslipidemia Trial in Worldwide (ARO-ANG3, Placebo)

Active, not recruiting
  • Mixed Dyslipidemia
  • Huntington Park, California
  • +23 more
Jun 27, 2022

Patient Tolerability and Success for Penile and Scrotal Urologic

Enrolling by invitation
  • Hydrocele
  • +11 more
  • Conscious sedation
  • Winnipeg, Manitoba, Canada
    Men's Health Clinic Manitoba
Nov 13, 2022

Infertility Trial in Anand (traditional drug treatment, Opt-IVF predicted dosage)

Recruiting
  • Infertility
  • traditional drug treatment
  • Opt-IVF predicted dosage
  • Anand, Gujrat, India
    Akansha Hospital and Research Institute
Nov 1, 2022

Obstetric Pain, Anesthesia, Local Trial (Electrical Epidural Stimulation Test (EST))

Not yet recruiting
  • Obstetric Pain
  • Anesthesia, Local
  • Electrical Epidural Stimulation Test (EST)
  • (no location specified)
Jul 21, 2022

Hepatocellular Carcinoma Trial in Taoyuan City (adagloxad simolenin/OBI-821, TACE)

Terminated
  • Hepatocellular Carcinoma
  • adagloxad simolenin/OBI-821
  • TACE
  • Taoyuan City, Taoyuan, Taiwan
    Linkou Chang Gung Memorial Hospital
May 4, 2021

Neovascular Age-related Macular Degeneration Trial in Worldwide (2.0 mg OPT-302, 2.0 aflibercept, Sham)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • 2.0 mg OPT-302
  • +2 more
  • Phoenix, Arizona
  • +182 more
Sep 6, 2022

Neovascular Age-related Macular Degeneration Trial in Worldwide (2.0 mg OPT-302, 0.5 mg ranibizumab, Sham)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • 2.0 mg OPT-302
  • +2 more
  • Phoenix, Arizona
  • +174 more
Sep 6, 2022

Response To Dengue Exposure Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rDENdelta30/31-7164)

Not yet recruiting
  • Response To Dengue Exposure
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Prostate Cancer Trial (Neoadjuvant treatment)

Not yet recruiting
  • Prostate Cancer
  • Neoadjuvant treatment
  • (no location specified)
Oct 19, 2022

Mixed Dyslipidemia Trial in Worldwide (ARO-APOC3, Placebo)

Recruiting
  • Mixed Dyslipidemia
  • Beverly Hills, California
  • +31 more
Aug 2, 2022

Schizophrenia Trial in Ukraine, United States (Risperidone ISM 75 mg, Risperidone ISM 100 mg)

Completed
  • Schizophrenia
  • Risperidone ISM 75 mg
  • Risperidone ISM 100 mg
  • Rogers, Arkansas
  • +23 more
Feb 24, 2022

Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)

Not yet recruiting
  • Recurrent Prostate Cancer After Surgery
  • Daily-adaptive Stereotactic Body Radiation Therapy
  • Rochester, New York
    Wilmot Cancer Institute - Dept of Radiation Oncology
Jul 7, 2023